- Open Access
Is there potential for the future provision of triage services in community pharmacy?
Journal of Pharmaceutical Policy and Practice volume 9, Article number: 29 (2016)
Worldwide the demands on emergency and primary health care services are increasing. General practitioners and accident and emergency departments are often used unnecessarily for the treatment of minor ailments. Community pharmacy is often the first port of call for patients in the provision of advice on minor ailments, advising the patient on treatment or referring the patient to an appropriate health professional when necessary. The potential for community pharmacists to act as providers of triage services has started to be recognised, and community pharmacy triage services (CPTS) are emerging in a number of countries. This review aimed to explore whether key components of triage services can be identified in the literature surrounding community pharmacy, to explore the evidence for the feasibility of implementing CPTS and to evaluate the evidence for the appropriateness of such services.
Systematic searches were conducted in MEDLINE, EMBASE and International Pharmaceutical Abstracts (IPA) databases from 1980 to March 2016.
Key elements of community pharmacy triage were identified in 37 studies, which were included in the review. When a guideline or protocol was used, accuracy in identifying the presenting condition was high, with concordance rates ranging from 70 % to 97.6 % between the pharmacist and a medical expert. However, when guidelines and protocols were not used, often questioning was deemed insufficient. Where other health professionals had reviewed decisions made by pharmacists and their staff, e.g. around advice and referral, the decisions were considered to be appropriate in the majority of cases. Authors of the included studies provided recommendations for improving these services, including use of guidelines/protocols, education and staff training, documentation, improving communication between health professional groups and consideration of privacy and confidentiality.
Whilst few studies had specifically trialled triage services, results from this review indicate that a CPTS is feasible and appropriate, and has the potential to reduce the burden on other healthcare services. Questions still remain on issues such as ensuring the consistency of the service, whether all pharmacies could provide this service and who will fund the service.
The demands on primary health care services worldwide are growing , largely due to an ageing population which has subsequently led to increased strain on the primary health care workforce [2–5]. In order to overcome such challenges, primary health care systems have evolved to encompass new services and, in many countries, extended roles for community pharmacists [6, 7].
Triage has traditionally been described as the sorting and allocation of treatment to casualties, particularly in battlefield and disaster situations . In this model, casualties are sorted based on a system of priority, designed to maximise the number of survivors . The definition has been extended to refer to “The assessment of patients on arrival to decide how urgent their illness or injury is and how soon treatment is required” . An example of the latter description includes the role of nurses in emergency rooms . More recently, the term triage has been used increasingly to describe non-emergency situations in healthcare: one such example is Healthline in New Zealand, where members of the public can speak to a registered nurse who provides advice and directs patients to the most appropriate service .
Community pharmacy is recognised for its role as a common first port of call for patients in the provision of advice on minor ailments , and referral to an appropriate health professional when necessary . Community pharmacies are available in most localities, often open at times when general practitioner (GP) services are not available, and no appointment is necessary to consult with a pharmacist [4, 5]. This raises the question of whether there is an opportunity to translate the concept of triage to a formalised service provided by community pharmacists.
It could be argued that elements of triage services in community pharmacy already exist. Worldwide, a number of medicines have been reclassified from prescription-only medicines to be available over-the-counter, as medicines available only from pharmacies . Examples include chloramphenicol for the treatment of bacterial conjunctivitis  and trimethoprim for uncomplicated urinary tract infections  in New Zealand. This reclassification enables appropriately trained pharmacists to determine when to treat and when to refer the patient to their GP or other health professional, and thus includes an element of triage, although the skills and processes used to undertake this task are not currently referred to in this way.
Developing effective triage services in community pharmacy has the potential to reduce pressure on other health services, by reducing costs associated with unnecessary use of other more expensive healthcare services, such as visits to GPs and accident and emergency departments (EDs) at hospitals. In the year 2006 to 2007, it was reported in the United Kingdom (UK) that there were 57 million consultations with GPs involving a minor ailment, which had an estimated cost of £2 billion per annum . In addition, a separate UK-based study found that of 353 observed GP consultations, 31 % were for minor ailments, of which 59 % could have been managed in a community pharmacy .
Research undertaken in Australia found that if the resources devoted to minor ailments were dealt with through community pharmacies, this redirection of resources could potentially free-up the equivalent of 500 to 1,000 full time GPs to treat more serious health problems . In addition to GP visits, estimates have been made of the minor ailments managed in EDs and afterhours clinics, which could have been managed by a pharmacist [17–20], ranging from 5.3 %  to 8 % at EDs , and 28 % of adult attendances at afterhours primary care centres .
The potential for community pharmacists to act as providers of triage services has started to be recognised, and community pharmacy triage services are emerging in a number of countries. For example, the Swiss Pharmacists’ Association has launched netCare in a select number of pharmacies . netCare is a primary triage service using a structured decision-tree for 24 common conditions, where pharmacists can request a real-time video consultation with a doctor if necessary. In addition, minor ailment schemes have been implemented, for example, the Community Pharmacy Minor Ailments Scheme (MAS) [6, 21], which began in Scotland and is now available at some pharmacies across the UK. These minor ailment schemes have elements of triage within their structure and formalise the primary health care role of the community pharmacist for certain minor ailments, whereby designated patients can consult a pharmacist and, if necessary, obtain a pharmacist-prescribed medication from a limited formulary . In Canada, two provinces (Nova Scotia and Saskatchewan) added minor ailments as an expanded aspect of practice in 2011. This new legislation broadened pharmacists’ scope of practice, enabling them to prescribe certain medications for minor self-limiting and self-diagnosed ailments from a list of agents previously only able to be prescribed by a doctor .
The aim of this review is to explore the potential for community pharmacy provision of triage services. Specific objectives were:
To explore whether key components of triage services can be identified in literature surrounding community pharmacy
To explore the evidence for the feasibility of implementing community pharmacy triage services (CPTS)
To evaluate the evidence of appropriateness of such services
Materials and methods
Working definition of triage
For the purposes of this paper, we used a definition of community pharmacy triage reported by Chapman et al. , In their report they described triage in this way “The provision of advice about how best to manage health issues – whether with a medical product or device or with non-drug measures, whether to seek assistance from a doctor or other health professional, and with what sense of urgency – is a primary health care service commonly provided by community pharmacies”.
Definition of appropriateness
This review aimed to evaluate the evidence of appropriateness of CPTS. For the purposes of this study, appropriateness was considered in the light of clinical appropriateness and acceptability by other health professionals and patients.
We performed systematic searches in MEDLINE, EMBASE and International Pharmaceutical Abstracts (IPA) databases from 1980 to March 2016. The search strategy was designed to retrieve studies conducted on triage-like services in community pharmacy settings. Triage in community pharmacy is a relatively new and developing concept that does not have a clear definition; an initial search revealed that published literature on community pharmacy seldom uses the word triage; therefore, this review used several synonyms for the relevant activities that comprise our working definition of triage in community pharmacy to capture articles related to this concept.
Our search included both mapped and unmapped terms, which are illustrated in Fig. 1. In addition, the following text words and MeSH/EMTREE terms were used to identify additional relevant papers: (Mapped terms: pharmaceutical services OR pharmacies OR pharmacist OR community pharmacy services; unmapped terms: pharmac* OR community pharmac* OR retail pharmac* OR drugstore OR drug store) AND (Mapped terms: self medication OR self care OR non-prescription drugs OR behind the counter drugs OR referral and consultation OR gatekeeping OR triage OR primary healthcare OR patient centred care OR counselling; unmapped minor ailment).
Inclusion criteria were formulated in relation to the research aims. First, papers were included only if they referred to community pharmacy settings and included a triage service (as defined above) in patients with a first presentation of a medical complaint. We excluded studies that were not written in English, did not have a full text article available, reviews, commentaries and letters to the editor. We also excluded studies that focused on services for monitoring chronic/long term conditions or were focussed on prescription services.
Data extraction and analysis
Two researchers (LC, JM) independently extracted study characteristics, using an extraction table. One researcher (LC) compared all extracted data and discussed discrepancies with other researchers (JShe, MM) when necessary. A summary of the data extracted from the studies is presented in Table 1. This includes the study design, aims, measurements taken, types of conditions, number of referrals and a summary of results. In addition, we recorded whether each study included the characteristics of community pharmacy triage, based on our working definition, in their study description: i.e. contact with the patient or caregiver, questions asked, urgency and level of care decided, advice given and decision made to treat or refer. Evidence of appropriateness in decision making, appropriateness of referral, adherence to referral advice, and the recommendations from the authors were extracted from the studies.
Screening, selection and included studies
A diagrammatic depiction of the search strategy is included in Fig. 1. The searches in MEDLINE, EMBASE and IPA resulted in a total of 3597 titles. Studies were excluded if they were not related to community pharmacy triage or did not report outcomes related to patients. Duplicates were also excluded. The remaining studies (n = 37) reported aspects of triage in community pharmacy between 1980 and 2016 (Table 1). The studies were undertaken in the UK (n = 16), Europe (n = 13), Australia (n = 6), Canada (n = 1) and Singapore (n = 1).
Three main methodologies were used across the studies. Twenty-two of the studies in this review were cross-sectional observational studies with natural patients. Ten studies used a pseudo-patient methodology, which in our review was defined as studies where a trained person presented to a pharmacy asking for advice or a specific product as part of a pre-determined case, and consultation was recorded and feedback given to the pharmacy. Lastly, questionnaires completed by healthcare providers and/or patients (n = 5) were also used where they described the aspects of a community pharmacy triage service.
Types of conditions
Thirteen studies included any minor ailment in community pharmacies across a given time period, whilst others presented results on specific conditions across a time period (n = 24). Observational studies of natural patients evaluated measures surrounding non-specific minor ailment presentations [11, 23–25]. Those that focused on specific condition presentations were: headache , back pain , head lice infestations , two studies focussing on erectile dysfunction [28, 29] and four on gastrointestinal presentations [30–33]. All studies that used the pseudo-patient methodology focussed on specific conditions: allergic conjunctivitis , diarrhoea in an infant , abdominal pain , a gastrointestinal presentation , headache [36, 37], cough , insomnia , vaginal thrush  and three studies looked at ulcers/lesions in the mouth [41–43]. Four of the questionnaire-based studies investigated specific conditions: chloramphenicol use for bacterial conjunctivitis , dermatological conditions , lower bowel conditions  and genital conditions .
Evidence for decision making
Appropriate decision-making with regards to treatment or referral requires eliciting a patient’s relevant history via questioning. The appropriateness in decision making was evaluated by two main methods, observing community pharmacy staff actions with the use of specific guidelines or protocols and observing community pharmacy staff actions without their use.
Ten of the studies used current or newly developed guidelines which covered asking appropriate questions and differentially diagnosing presenting conditions, and identifying requirements for referral [25, 26, 28–32, 44, 48, 49]. Other studies evaluated decision-making by recording the number of questions asked and comparing them with a pre-determined list of questions [33, 34, 36–40]; and/or the use of mnemonics such as WWHAM (Who is it for? What are the symptoms? How long? Action tried? Medications taking?) [24, 35, 40].
When a guideline or protocol was used, accuracy in identifying the presenting condition was high with concordance rates ranging from 70 % to 97.6 % [25, 28, 29, 32]. In comparison, in studies where no specific guidelines/protocols were used, the authors of those studies concluded that too few questions had been asked to obtain sufficient information to undertake a valid analysis [34–36]. For example, results from the study by Berger et al.  found that 95 % of community pharmacy staff asked at least one question to assess the diagnosis in patients presenting with a condition, but only 47 % in a case where a specific product request was requested.
Fifteen studies evaluated the appropriateness of the decision made to treat or refer. The studies that used pseudo-patients compared the interaction with the ‘patient’ to predetermined optimal outcomes [34–39, 41–43]. Bilkhu et al.  found that the differential diagnosis was lacking in community pharmacy, whereby questions were not asked to distinguish the different types of conjunctivitis. In addition, some studies found that too few questions were asked to adequately assess the presented situation [34–36]. Schneider and colleagues  and Watson and colleagues  found that the likelihood of adequate assessment increased with the number of questions asked.
In six of the natural patient studies, another health professional reviewed the outcome [25, 29, 32, 46, 47, 50]. Marklund et al.  had a GP assess all referrals related to dyspepsia that were recorded by pharmacists; the study found that in 90 % of cases the GP agreed that the patient needed to be referred to the GP for either a prescription, or a medical examination. Westerlund and colleagues , had an independent doctor assess the self-care advice given by the pharmacist and found that it was appropriate in 97.6 % of cases. In the study by Blenkinsopp and colleagues a notification card was used to improve the communication between GPs and pharmacists. If the pharmacist decided that a patient should be referred to the doctor, a notification card was completed. The card was given to the patient to take with them to their doctor and a copy was stored at the pharmacy for their records. The results showed that 88 % of the referrals were appropriate according to the GP . In a separate study by Symonds et al. the medical specialist agreed with 90 % of the recommendations made by the pharmacist after a follow-up assessment .
In the questionnaire-based studies [46, 47], cases were given to the pharmacist who then had to make a decision on the necessity to refer. These decisions were then evaluated by a medical expert. Jiwa and colleagues  found a 70 % agreement between an expert panel and the pharmacist and Ralph et al.  reported that “many pharmacists were able to manage sexual health problems adequately”.
Between 66 % and 95.1 % of patients reported symptom relief or resolution in studies using a guideline or protocol [25, 30, 31, 48]. In the study that did not use a guideline or protocol, 86.8 % reported symptom relief or resolution . In the study by Krishnan et al.  patients who presented with dyspepsia were contacted at 7 days post consultation with the pharmacist. One group of pharmacies had a training intervention on guidelines for counselling of patients with dyspeptic disorders and another was a control group of pharmacies who did not have this training; patients who attended both control and intervention pharmacies reported an improvement in quality of life scores at day seven .
Referral rates, appropriateness of, and adherence to advice of referral
All studies, except two (n = 35), discussed the referral of patients to other healthcare providers by pharmacists or other community pharmacy staff. In addition, 27 studies (see Table 1) documented either the number of patients referred or the proportion of patients referred.
There was a wide variation in the proportion of patients referred to other health services after a pharmacist or community pharmacy staff consultation. When considering the referral rate in the natural patient studies which included any minor ailment presentation, a range of 6 %  to 9.1 %  was reported. When considering the condition-specific studies this range is much wider, varying from 12 %  for a study on patients presenting with dyspepsia to a 77 % referral rate in erectile dysfunction cases .
Nine studies used pseudo-patients and documented referral [34–39, 41–43]; seven of the studies used one scenario, and the other two had two different case scenarios [36, 37]. The most appropriate, predetermined outcome in eight of the cases used in these studies was referral [36–39, 41–43] and the number of recorded patient referrals ranged between 8.8 %  and 90 % . Three studies consisted of patient scenarios that were considered to be appropriately managed by a community pharmacy staff member; in one study no referrals were recommended , and the remaining two reported referral rates of 14 %  and 31 % .
Adherence to referral advice
Five studies included follow up with the patient, to evaluate what proportion had taken the advice of the pharmacist to visit another health professional. In four studies, [24, 28, 30, 31] 20 %–51 % of patients had taken the advice of the pharmacist. One study found 71 % patients acted on the advice of the pharmacist; in this case a referral card had been given to the patient .
Reverse referral interventions
Whilst some studies involved patients presenting at the pharmacy directly, others described a reverse intervention service. These services offered a patient, who was seeking an appointment with a GP or nurse for treatment for a minor ailment, the option of a consultation with the community pharmacist instead. In such instances the community pharmacist could refer the patient back to the GP when necessary [7, 51, 52]. Hassell and colleagues found that the referral rate back to the GP was only 3.6 %  in one of their studies and 6 %  in the other. One study investigated refugees approaching either the nurse, support worker or reception staff at the refugee hostel about a minor ailment. Instead of being given an appointment with a GP, they were offered a voucher which they could exchange at a community pharmacy for an appropriate over the counter medication free of charge, after a consultation with the pharmacist . This study had a low number of referrals (1.1 %) back to the GP .
Recommendations from study authors
Twenty seven studies included in this review noted recommendations on community pharmacy, based on their findings. These are summarised below.
Additional pharmacy staff education or training
Increased education, training or support for community pharmacy staff was suggested in eight of the studies in [33, 34, 39, 41, 42, 44, 45, 47]. In most cases, the recommendations were specific to the medical condition being studied, for example, appropriate advice for sexual health  and insomnia , differential diagnosis of ocular conditions [34, 44] and identifying signs of potential oral cancers with appropriate referral advice [41, 42]. In addition, Hafajee et al. recognised that there are a large number of dermatological presentations in pharmacy, and suggested increased education at both undergraduate and postgraduate levels .
Use of guidelines and protocols
Eleven of the studies suggested that guidelines or protocols be developed and used by community pharmacy [11, 22, 29–31, 34–36, 42, 46, 49]. For example, Hassell et al.  proposed that guidelines could be developed by pharmacists in conjunction with GPs, and a two way referral system could be established. Mehuys and colleagues  advocated for the use of structured questionnaires during consultations, with treatment options that ensured the recommendations made were evidence-based. Westerlund et al.  suggested that a model designed to diagnose and treat problems related to symptoms be used in the community pharmacy setting.
More emphasis on appropriate advice to customers was recommended by three studies [26, 35, 39]. Importantly, Vella et al., found that when customers asked for a specific product they were much less likely to be given advice on the use of that product . Furthermore, the provision of patient resources and educational material was suggested [28, 29, 45].
Documentation and integration of care
Three of the studies made recommendations surrounding documentation of customer consultations and/or increased communication with the healthcare professional to whom the patient was being referred [48, 50, 53]. One study noted that the use of a notification card given to the patient to take to the health professional to which they were referred, improved patients following through on referral advice by pharmacists. The authors also suggested that more information could be included on this card, for example any screening measurements that had been taken, for example blood pressure, and this was being trialled . Erni and colleagues  also proposed that future services needed better integration into the health system to ensure “its efficacy, safety, cost effectiveness and acceptance by patients”.
Documentation of patient consultations would also allow for follow-up treatment. It was suggested that there was a need for follow-up of some patients to ensure that appropriate care had been given and modification of treatment was made if necessary [28, 30].
Privacy and confidentiality
Phillips and colleagues  recognised the sensitive nature of certain conditions, and that some patients did not want to have a consultation in the pharmacy due to concerns about privacy. Having pharmacies with private consultation rooms may be beneficial for avoiding embarrassment and for ensuring confidentiality.
Access to the pharmacist
In the studies where it was considered that the most appropriate decisions were made [38, 42], pharmacists had conducted the consultation and thus the authors suggested that access to a pharmacist for consultations are a necessity.
Increased public awareness of pharmacist services
Chui et al.  recognised that education of the public about the services that pharmacists provide is important; in addition Hafejee and colleagues  noted that one inexpensive method to increase patients’ knowledge of the roles pharmacists can play in managing their skin problems was by the use of leaflets.
This review addressed the feasibility of, and evidence for a CPTS and attempted to identify the key characteristics of such a service that are described in the literature. This review has found that elements of a CPTS currently exist in community pharmacies; however, the components of this service may need revising as we move forward. The recommendations of the various authors identified key areas which would need to be addressed to ensure that the service is safe and effective in terms of the appropriateness of differential diagnoses and decisions to treat or refer.
Pharmacists were found to make appropriate differential diagnosis decisions in a number of studies. However, several studies that did not use guidelines/protocols noted that pharmacists or their staff did not ask sufficient questions to obtain enough information to allow them to accurately assess the patient’s condition. It is important for any consultation, whether the decision is to recommend treatment or to refer, to include adequate investigation using an appropriate number of pertinent questions. When guidelines/protocols were used this increased the appropriateness of the outcome [25, 28, 29, 32]; protocols can prompt appropriate questioning . However, to optimise their use this must be coupled with training and education; Alkhatib and colleagues  showed that despite the high compliance with protocol use in their study, 21.8 % of pharmacists felt they required additional training. Computerised decision support systems have been trialled in community pharmacy , and nurse-based triage  with some success. If this type of protocol system were to be utilised, logistics of use would have to be further tested in a community pharmacy environment. Regardless of whether the guidelines/protocols are computer-based on not, guidelines must be reviewed on a regular basis to ensure that the recommendations are evidence-based .
Cost analysis was conducted in two studies based in the UK, which estimated the cost savings when patients sought advice from the community pharmacy in comparison to GPs or EDs [6, 27]. Both of these studies concluded that there would be a significant cost benefit of schemes such as the MAS.
Overall, when the appropriateness of pharmacist referral decisions was evaluated by another health care expert, a high level of concordance was found. However, to our knowledge, there have been no studies that have looked at the appropriateness of treatment provided by pharmacists for patients using community pharmacy triage-like services; studies assessing the perspectives and health outcomes for patients are also scant. Whilst OTC medications can be effective in symptom control and resolution, and many minor ailments are likely to resolve without treatment, treatment with OTC medications has the potential to mask conditions or contribute towards diagnostic delay at a GP/ED. Varela et al.  reported that when a pseudo-patient presented with symptoms reflective of oral cancer, few patients were appropriately referred. Similarly, Scully and colleagues  found that fewer than 10 % of pharmacy staff recommended referral when a patient presented with a history suggestive of oral carcinoma. In both cases, if a patient was prescribed an OTC medication, this could delay presentation at the doctor for accurate diagnosis.
In order to reduce the risk of inappropriate diagnosis and inappropriate treatment, training and the use of guidelines and protocols have been advocated [25, 28, 29, 32], to ensure that a comprehensive and relevant patient history is taken, and to guide differential diagnosis. Hassell et al.  proposed that guidelines could be developed by pharmacists in conjunction with GPs, and Mehuys et al.  highlighted the need for evidence-based recommendations within such guidelines. Erni and colleagues  described the netCare triage service where 24 decision trees were developed. What is not yet known is whether the implementation of these guidelines would necessarily result in compliance. Alkhatib et al.  found that 55.5 % of pharmacists self-reported “always” using the specified protocol for the provision of ophthalmic chloramphenicol and a further 29.4 % used the protocol “usually”. Nonetheless, 6.7 % “never” used the protocol.
Varela-Centelles et al. reported that pharmacist interactions with patients led to a higher proportion of appropriate decisions being made  than when consultations were with pharmacy support staff. In a study by Sheridan et al., pharmacy assistants saw themselves as being the first point of contact within the pharmacy , and the same study also found that pharmacists perceived pharmacy assistants as “gatekeepers” to the pharmacist. For a CPTS, it is therefore important to ensure that pharmacy support staff have adequate training, and they know when to refer to the pharmacist. The use of protocols can guide this process. However, this then raises the question of whether a future CPTS should be restricted to accredited pharmacies where staff have undertaken specific training and the pharmacies meet certain criteria.
There have been contrasting perspectives from healthcare professionals with respect to the community pharmacy’s role in the triage of minor ailments. Morris and colleagues surveyed GPs’ opinions on the treatment of minor ailments by GPs and potentially pharmacists . Whilst there were favourable responses toward pharmacists in this role from some, others expressed concerns about the quality of pharmacists’ advice they did not know and only 50.9 % of GPs would recommend their patients seek advice from a pharmacist .
Patients have also been reported to have mixed perceptions about the role of pharmacists in healthcare. A study by Gidman et al.  described opinions of the public toward the role of the pharmacists and pharmacy services, including their role in the management of minor ailments. Some patients viewed the role of the pharmacist as a dispenser of medicines prescribed by the doctor and raised concerns about the incomplete nature of the services provided by community pharmacies and their lack of communication with GPs. On the other hand, others viewed pharmacists’ knowledge of OTC products to be greater than that of the GP and expressed their trust in the pharmacist as being able to competently deal with minor self-limiting conditions . Erni and colleagues  proposed that future triage services need better integration into the health system. This notion was also highlighted by Blenkinsopp et al.  and Marklund et al.  where referral cards were used between pharmacists and GPs.
Integrated computer-based healthcare services which link pharmacy and GP data, for example, are attainable. Whilst the studies in this review did not discuss whether IT integration was available, examples do exist. In New Zealand, “Testsafe” is a medical information sharing service for certain areas of the country, which gives healthcare providers access to diagnostic test results, reports and medicines information for their patients, in addition what medications have been dispensed by community pharmacists . Such a system could be used for pharmacists to report on CPTS interactions.
This review did not focus on the funding of CPTS in pharmacies; however, it is evident that cost is an important factor in considering the service’s feasibility. First of all, there is the issue of whether patients will pay for such a service. If a patient payment is required, one needs to consider whether they will use the service, in situations where GP and ED visits are free of charge, as in the UK. Conversely, in New Zealand, for example, unless you are under the age of 13, there is a cost associated with visiting a GP and thus a CPTS which is free of charge may be more attractive to patients. If no patient charge is to be made, this leaves the issue of who would fund the service.
One purpose of a recognised CPTS is to reduce the burden on other health providers such as GPs and EDs. Hassell et al.  found that diverting those seeking treatment for minor ailments from GPs to community pharmacies resulted in a 37.8 % reduction in GP consultations for 12 self-limiting conditions, although the overall GP workload did not decrease.
New and emerging services pertaining to the provision of advice and treatment for minor ailments, for example the MAS, are being utilised in some countries [6, 22, 52]. When questioned, patients who have used services such as the MAS, reported that if these pharmacy services were not available, they would have visited a GP or emergency services . In addition, reverse referral interventions appear promising in reducing the workload of the GP for minor ailment consultations as they have resulted in few referrals back to the GP [7, 11].
An ideal CPTS needs to be one that is accessible  and that the public is aware of [28, 53], with sufficient resources, including competent staff that are available to appropriately question, diagnose and then either resolve or refer patients to the appropriate healthcare provider when necessary. Furthermore, communication and an interprofessional collaborative relationship between pharmacists and other healthcare professionals are integral to the success of a CPTS. Whilst a previous model developed referral cards to be taken by the patient to the referred provider , integrated computer-based systems may also be useful [25, 31]. Furthermore, having mutual support between GPs and pharmacists could allow for the potential of a two-way referral system . In the netCare model, access to a dedicated GP to request a second opinion was available to pharmacists, which was used in only 17 % of cases . This back-up consultation access may be valuable. Finally, documentation of the triage interaction is an important aspect of a potential service, and would allow for follow-up consultations to be arranged and medical notes available for re-assessment, and also allow the potential for auditing of services for quality.
It is important to differentiate community pharmacy triage from ED triage. In ED, the triage of patients involves the presenting condition being assessed for urgency and a decision on how soon treatment is required , and hence ED triage encompasses the management of the full range of presentations from minor to life threatening . However, in community pharmacy, an additional factor needs to be acknowledged – that there are many situations in which pharmacists are not able to treat, even if they are considered relatively minor and non-urgent. Thus triage in community pharmacy is not the same as triage in ED. The importance of a clear definition of CPTS is therefore essential.
Whilst the definition used in this review (from Chapman et al. ) describes elements of this service, the variability in current triage services suggests that this may not be sufficient to adequately define a CPTS. Community pharmacy triage may be best described as structured service which responds to contact initiated by the patient or caregiver for advice or a specific product request. This is then followed up with appropriate questioning with the decision to treat or refer to another health practitioner. Ideally, this should then be documented in the patient’s notes held in the pharmacy and available to the GP in the patient’s electronic health record, in an integrated health system. For the presentations that do not require referral to another health care provider, treatment and advice should be recommended based on evidence-based information.
We must also bear in mind that countries worldwide differ in their provision of prescription and non-prescription medicines. There are differences in regulations about where certain medications can be legally sold and by whom. For example, in the United States  all non-prescription medications do not have to be sold in a pharmacy setting. This is in stark contrast to many countries in Europe where all medicines have to be sold in a pharmacy .
Furthermore, we chose to define “appropriateness” in the light of clinical acceptability by other health professionals and patients. However, there is lack of clarity around how or whether appropriateness could also be expanded to include other parameters outside of our criteria. This review did not focus on the funding of CPTS in pharmacies; however, it is evident that cost is an important factor in considering such a service’s feasibility, which could be a focus for future reviews.
Community pharmacists are seen as the most accessible health professionals  and are ideally placed to provide advice on both symptom presentations and OTC medication requests [61, 62]. Some have argued that their accessibility makes community pharmacy well suited to offer extended health services, providing convenient access points to those who are unable to use other services . This review explored the potential for the future provision of more formally recognised triage services by evaluating the feasibility and the appropriateness of such services. From this review it is evident that the development and use of guidelines/protocols for the management of minor ailments within community pharmacies facilitates accurate assessment of a patient’s condition with respect to whether a patient needs referral to another health care professional, and the urgency of this, or whether they can be safely treated in the pharmacy setting. Structured protocols along with adequate staff training would ensure the elicitation of a comprehensive and accurate patient history resulting in appropriate recommendations for the management of the condition. Such a service would be likely to reduce the burden on other health care providers. However, while we have highlighted the feasibility of such a service, we also acknowledge that a number of questions remain unanswered.
Community pharmacy triage services
International pharmaceutical abstracts
Minor ailments scheme
Morris CJ, Cantrill JA, Weiss MC. GPs’ attitudes to minor ailments. Fam Pract. 2001;18(6):581–5.
Bodenheimer T, Pham HH. Primary care: current problems and proposedsolutions. Health Aff. 2010;29(5):799–805.
Evans R et al. Apocalypse No : population aging and the future of health care systems. Social and Economic Dimensions of an Ageing Population, 2001. Research paper 59.
Anonymous. Public health and aging: trends in aging—United States and worldwide. JAMA. 2003;289(11):1371–3.
Cornwall J, JA. Davey. Impact of population ageing in New Zealand on the demand for health and disability support services and workforce implications New Zealand Institute for Research on Ageing (NZiRA) and the Health Services Research Centre (HSRC), Victoria University of Wellington. 2004. https://www.health.govt.nz/system/files/documents/publications/cornwallanddavey.pdf. Accessed 30 Sept 2016.
Baqir W, et al. Cost analysis of a community pharmacy ‘minor ailment scheme’ across three primary care trusts in the North East of England. J Public Health. 2011;33(4):551–5.
Bojke C, et al. Increasing patient choice in primary care: the management of minor ailments. Health Econ. 2004;13(1):73–86.
Merriam Webster dictionary. Full Definition of triage. Available from: http://www.merriam-webster.com/dictionary/triage. Accessed 30 Sept 2016.
Health, N.Z.M.o. Emergency department triage. 2011. Available from: http://www.health.govt.nz/our-work/hospitals-and-specialist-care/emergency-departments/emergency-department-triage. Accessed 30 Sept 2016.
Ministry of Health. Healthline. 2015. Available from: http://www.health.govt.nz/your-health/services-and-support/health-care-services/healthline. Accessed 30 Sept 2016.
Hassell K, et al. A pathway to the GP: the pharmaceutical ‘consultation’ as a first port of call in primary health care. Fam Pract. 1997;14(6):498–502.
Gauld NJ, et al. Widening consumer access to medicines through switching medicines to non-prescription: a six country comparison. PLoS One. 2014;9(9):e107726.
Anonymous. Chloramphenicol eye drops approved as pharmacy medicine for treatment of bacterial conjunctivitis. Pharm J. 2005;274:697.
Gauld N. Improving access to urinary tract infection treatment: the reclassification of trimethoprim. SelfCare. 2012;3(6):115–20.
MINA study, Community Pharmacy Management of Minor Illness. Pharmacy Research UK, 2014.
ASMI Media Release. Available from: http://www.i2p.com.au/article/asmi-media-releases-september-2009. Accessed 30 Sept 2016.
Fielding S, et al. Estimating the burden of minor ailment consultations in general practices and emergency departments through retrospective review of routine data in North East Scotland. Fam Pract. 2015;32(2):165–72.
Proprietary Association of Great Britain. Making the case for the self care of minor ailments. 2009. Available from: http://www.selfcareforum.org/wp-content/uploads/2011/07/Minorailmentsresearch09.pdf. Accessed 30 Sept 2016.
Bednall R, et al. Identification of patients attending accident and emergency who may be suitable for treatment by a pharmacist. Fam Pract. 2003;20(1):54–7.
Welle-Nilsen LK, et al. Minor ailments in out-of-hours primary care: an observational study. Scand J Prim Health Care. 2011;29(1):39–44.
Bellingham C. How the minor ailments service works. Pharm J. 2004;272(7284):115–6.
Mansell K, et al. Evaluating pharmacist prescribing for minor ailments. Int J Pharm Pract. 2015;23(2):95–101.
Chapman C, J Marriott, D. van den Bosch. The Nature, Extent and Impact of Triage Provided By Community Pharmacy in Victoria. Pharmacy Guild of Australia; 2010. http://guild.org.au/services-programs/research-and-development/archive---fourth-agreement/iig-008
Coelho RB, Costa FA. Impact of pharmaceutical counseling in minor health problems in rural Portugal. Pharm Pract. 2014;12(4):451.
Westerlund T, Andersson IL, Marklund B. The quality of self-care counselling by pharmacy practitioners, supported by IT-based clinical guidelines. Pharm World Sci. 2007;29(2):67–72.
Vella E, et al. Development of protocols for the provision of headache and back-pain treatments in Maltese community pharmacies. Int J Pharm Pract. 2009;17(5):269–74.
Philips Z, et al. The role of community pharmacists in prescribing medication for the treatment of head lice. J Public Health Med. 2001;23(2):114–20.
Martin Morales A, et al. Community pharmacy detection of erectile dysfunction in men with risk factors or who seek treatment or advice but lack a valid prescription. J Sex Med. 2013;10(9):2303–11.
Symonds T, et al. A feasibility study comparing pharmacist and physician recommendations for sildenafil treatment. J Sex Med. 2011;8(5):1463–71.
Mehuys E, et al. Self-medication of upper gastrointestinal symptoms: a community pharmacy study. Ann Pharmacother. 2009;43(5):890–8.
Westerlund T, et al. Evaluation of a model for counseling patients with dyspepsia in Swedish community pharmacies. Am J Health Syst Pharm. 2003;60(13):1336–41.
Marklund B, et al. Referrals of dyspeptic self-care patients from pharmacies to physicians, supported by clinical guidelines. Pharm World Sci. 2003;25(4):168–72.
Krishnan HS, Schaefer M. Evaluation of the impact of pharmacist’s advice giving on the outcomes of self-medication in patients suffering from dyspepsia. Pharm World Sci. 2000;22(3):102–8.
Bilkhu P, et al. The management of ocular allergy in community pharmacies in the United Kingdom. Int J Clin Pharm. 2013;35(2):190–4.
Driesen A, Vandenplas Y. How do pharmacists manage acute diarrhoea in an 8-month-old baby? A simulated client study. Int J Pharm Pract. 2009;17(4):215–20.
Rutter PM, Horsley E, Brown DT. Evaluation of community pharmacists’ recommendations to standardized patient scenarios. Ann Pharmacother. 2004;38(6):1080–5.
Berger K, Eickhoff C, Schulz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther. 2005;30(1):45–57.
Schneider CR, et al. Provision of primary care to patients with chronic cough in the community pharmacy setting. Ann Pharmacother. 2011;45(3):402–8.
Kippist C, et al. How do pharmacists respond to complaints of acute insomnia? A simulated patient study. Int J Clin Pharm. 2011;33(2):237–45.
Watson MC, et al. Factors predicting the guideline compliant supply (or non-supply) of non-prescription medicines in the community pharmacy setting. Qual Saf Health Care. 2006;15(1):53–7.
Evans MJ, Gibbons AJ. Advice given in community pharmacies to patients with possible oral carcinoma. Br J Oral Maxillofac Surg. 2005;43(3):253–5.
Varela-Centelles P, et al. Oral cancer awareness at chemist’s and herbalist’s shops: new targets for educational interventions to prevent diagnostic delay. Oral Oncol. 2012;48(12):1272–5.
Scully C, Gill Y, Gill Z. How community pharmacy staff manage a patient with possible oral cancer. Br J Oral Maxillofac Surg. 1989;27(1):16–21.
Alkhatib L, et al. An evaluation of the reclassification of ophthalmic chloramphenicol for the management of acute bacterial conjunctivitis in community pharmacies in Western Australia. Int J Pharm Pract. 2015;23(2):111–20.
Hafejee A, Coulson IH. Community pharmacists’ role in managing common skin problems. Br J Dermatol. 2006;155(6):1297.
Jiwa M, Spilsbury K, Duke J. Do pharmacists know which patients with bowel symptoms should seek further medical advice? A survey of pharmacists practicing in community pharmacy in Western Australia. Ann Pharmacother. 2010;44(5):910–7.
Ralph SG, Preston A, Clarke J. Over-the-counter advice for genital problems: the role of the community pharmacist. Int J STD AIDS. 2001;12(8):513–5.
Erni P, et al. netCare, a new collaborative primary health care service based in Swiss community pharmacies. Res Soc Adm Pharm. 2016;12(4):622–6.
Jiwa M, et al. Piloting and validating an innovation to triage patients presenting with cough to community pharmacies in Western Australia. Qual Prim Care. 2012;20(2):83–91.
Blenkinsopp A, Jepson M, Drury M. Using a notification card to improve communication between community pharmacists and general practitioners. Br J Gen Pract. 1991;41(344):116–8.
Hassell K, et al. Managing demand: transfer of management of self limiting conditions from general practice to community pharmacies. BMJ. 2001;323(7305):146–7.
Parmentier H, et al. Community pharmacy treatment of minor ailments in refugees. J Clin Pharm Ther. 2004;29(5):465–9.
Chui WK, Li SC. Advice-giving on self-medication: perspectives of community pharmacists and consumers in Singapore. J Clin Pharm Ther. 2005;30(3):225–31.
Huibers L, et al. Safety of telephone triage in out-of-hours care: a systematic review. Scand J Prim Health Care. 2011;29(4):198–209.
Marklund B, et al. Computer-supported telephone nurse triage: an evaluation of medical quality and costs. J Nurs Manag. 2007;15(2):180–7.
Hanna LA, Hughes CM. ‘First, do no harm’: factors that influence pharmacists making decisions about over-the-counter medication: a qualitative study in Northern Ireland. Drug Saf. 2010;33(3):245–55.
Sheridan J, et al. Can I help you? A qualitative study of pharmacist and pharmacy assistant views on the role of pharmacy assistants in New Zealand. Int J Pharm Pract. 2011;19(4):228–35.
Gidman W, Cowley J. A qualitative exploration of opinions on the community pharmacists’ role amongst the general public in Scotland. Int J Pharm Pract. 2013;21(5):288–96.
Testsafe. Care connect testsafe. 2011. Available from: http://www.testsafe.co.nz/Home.aspx. Accessed 30 Sept 2016.
Ministry of Health. Emergency department triage. Available from: http://www.health.govt.nz/our-work/hospitals-and-specialist-care/emergency-departments/emergency-department-triage. Accessed 30 Sept 2016.
Ngwerume K, et al. An evaluation of an intervention designed to improve the evidence-based supply of non-prescription medicines from community pharmacies. Int J Pharm Pract. 2015;23(2):102–10.
Simmons-Yon A, et al. Understanding pharmacists’ experiences with advice-giving in the community pharmacy setting: a focus group study. Patient Educ Couns. 2012;89(3):476–83.
Maunder PE, Landes DP. An evaluation of the role played by community pharmacies in oral healthcare situated in a primary care trust in the north of England. Br Dent J. 2005;199(4):219–23. discussion 211.
Watson MC, et al. A cohort study of influences, health outcomes and costs of patients’ health-seeking behaviour for minor ailments from primary and emergency care settings. BMJ Open. 2015;5(2):e006261.
We would like to acknowledge the NZ Pharmacy Education and Research Foundation (NZPERF) and the Pharmacy Guild of NZ for the funding for two summer studentships that contributed to this work.
JM and RG received funding from the Pharmacy Guild of New Zealand and the New Zealand Pharmacy Education and Research Foundation for work on summer studentships which contributed to this paper. The views expressed in this paper do not necessarily reflect the views of these organisations, which had no involvement in the drafting of this paper.
Availability of data and materials
Not applicable – this is a review of current literature.
LC: conception, extraction of data, analysis, interpretation, writing the review, revising and given final approval. JM: extraction of data, revising and given final approval. RG: extraction of data, revising and given final approval. TA: conception, revising and given final approval. MJ: conception, revising and given final approval. MM: conception, interpretation, revising and given final approval. JSha: conception, interpretation, drafting and revising and given final approval. JShe: conception, interpretation, drafting and revising and given final approval.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
About this article
Cite this article
Curley, L.E., Moody, J., Gobarani, R. et al. Is there potential for the future provision of triage services in community pharmacy?. J of Pharm Policy and Pract 9, 29 (2016). https://doi.org/10.1186/s40545-016-0080-8
- Community pharmacy services
- Primary health care
- Patient outcome assessment